ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
A Maintenance Extension of Phase I Pilot Study of Chimeric Anti-CD4 Antibody M-T412 in Patients With Multiple Sclerosis

This study has been completed.
Information provided by Office of Rare Diseases (ORD)
Please refer to this study by its ClinicalTrials.gov identifier: NCT00004816


Sponsors and Collaborators
National Center for Research Resources (NCRR)
Stanford University

Investigators
Study Chair:     Lawrence Steinman     Stanford University    


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act
U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services



Links to all studies - primarily for crawlers